The Immunology Core will perform a vital role in coordinating the research activities of Project Leaders within the Program Project, """"""""Host Defense Against HIV-related Pulmonary Infections"""""""". The mission of this Core is to supply state of the art techniques and procedures for the functional and morphological analysis of cells and tissues in the immune system, lung, and other organs in various models of infections. Quality control will be the first priority of this Core. The Core will administer, standardize, and perform daily analytical procedures to support ongoing research projects, and in addition, will develop novel assays to increase the flexibility of the Program Project-associated research. The specific objectives of the Immunology Core are: 1) to perform single and multiple color phenotypic and functional analysis of immune effector cells, memory cells, stem cells, and other types of cells and organisms by flow cytometry; 2) to perform sorting of cells by flow cytometry for isolation, enrichment, and cloning of cells with or without gene transfection; 3) to conduct analysis of inflammatory mediator profiles in biological samples by Luminex-based multiplex immunoassays; 4) to conduct analysis of gene and gene expression by real-time quantitative PCR or RT-PCR; and 5) to carry out histological, immunohistological, and functional analysis of cells and microbes by conventional, fluorescent, and confocal microscopy. The Immunology Core will serve as a base for technical training of personnel from each research component to use the facilities, procedures, and analyses employed by the Core. Professionals and specialists in the Core will also consult on data analysis and documentation in support of research in the Program Project.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL076100-01
Application #
6781606
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2003-12-01
Project End
2008-11-30
Budget Start
2003-12-01
Budget End
2005-01-31
Support Year
1
Fiscal Year
2004
Total Cost
$267,850
Indirect Cost
Name
Louisiana State University Hsc New Orleans
Department
Type
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Samuelson, Derrick R; Burnham, Ellen L; Maffei, Vincent J et al. (2018) The respiratory tract microbial biogeography in alcohol use disorder. Am J Physiol Lung Cell Mol Physiol 314:L107-L117
Samuelson, Derrick R; Shellito, Judd E; Maffei, Vincent J et al. (2017) Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLoS Pathog 13:e1006426
Goldsmith, Felicia; Guice, Justin; Page, Ryan et al. (2017) Obese ZDF rats fermented resistant starch with effects on gut microbiota but no reduction in abdominal fat. Mol Nutr Food Res 61:
Ruan, Sanbao; Cai, Yang; Ramsay, Alistair J et al. (2017) B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection. Vaccine 35:672-679
Maffei, Vincent J; Kim, Sangkyu; Blanchard 4th, Eugene et al. (2017) Biological Aging and the Human Gut Microbiota. J Gerontol A Biol Sci Med Sci 72:1474-1482
Byerley, Lauri O; Samuelson, Derrick; Blanchard 4th, Eugene et al. (2017) Changes in the gut microbial communities following addition of walnuts to the diet. J Nutr Biochem 48:94-102
Naftolin, Frederick; Mehr, Holly; Fadiel, Ahmed (2016) Sex Steroids Block the Initiation of Atherosclerosis. Reprod Sci 23:1620-1625
Jolley, Sarah E; Alkhafaf, Qasim; Hough, Catherine et al. (2016) Presence of an Alcohol Use Disorder is Associated with Greater Pneumonia Severity in Hospitalized HIV-Infected Patients. Lung 194:755-62
Ruan, S; Samuelson, D R; Assouline, B et al. (2016) Treatment with Interleukin-7 Restores Host Defense against Pneumocystis in CD4+ T-Lymphocyte-Depleted Mice. Infect Immun 84:108-19
Lammi, Matthew R; Ghonim, Mohamed A; Pyakurel, Kusma et al. (2016) Treatment with intranasal iloprost reduces disease manifestations in a murine model of previously established COPD. Am J Physiol Lung Cell Mol Physiol 310:L630-8

Showing the most recent 10 out of 49 publications